Products live on Sephora

Cellular Goods PLC
17 May 2023
 

Press release

 

17 May 2023

 

 Cellular Goods PLC

 

("Cellular Goods" or "the Company")

 

Products live on Sephora

 

Further to the announcement of 10 May 2023, Cellular Goods is pleased to announce that it has commenced selling its 'Look Better' (skincare) range and selected products from its 'Gift Better' (gifting) line on Sephora.co.uk. Ten products in total are available, ranging in price from £32 to £99 each.

 

The launch is part of the Company's strategy to drive revenues by expanding its online sales channel with major retail brands.

 

Darcy Taylor, chairman and interim CEO, commented: "We're thrilled that our Look Better and Gift Better ranges are on sale at Sephora, and are excited to be working alongside them to bring our next-generation skincare products to a wider audience."

 

For further information please contact:

Cellular Goods


Darcy Taylor

Chairman and interim CEO

Neil Thapar

Investor Relations

via Tancredi +44 207 887 7633

 

+44 787 645 5323

First Sentinel Corporate Finance


Corporate Broker & Advisor

Brian Stockbridge

 

+44 7876 888 011

Novum Securities

 

Corporate Broker

Colin Rowbury

Jon Belliss

 

 

+44 207 399 9427

Tancredi Intelligent Communication


Media Relations

Helen Humphrey

Charlie Hobbs

cellulargoods@tancredigroup.com

 

+44 744 922 6720

+44 789 755 7112

 

About Cellular Goods PLC:

Cellular Goods develops and markets premium quality skincare and wellness products based on proprietary formulations incorporating biosynthetic lab-made cannabinoids. Our branded products are efficacy-led and research-backed and available online in the UK and US. The Company is incorporated in the UK and listed on the Main Market of the London Stock Exchange. For more information, visit www.cellular-goods.com.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Cel AI (CLAI)
UK 100

Latest directors dealings